CIM
BMY icon

Contravisory Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Contravisory Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-448
Closed -$24.2K – 376
2025
Q4 		$24.2K Sell
448
-2,506
-85% -$121K ﹤0.01% 288
2025
Q3 		$133K Sell
2,954
-133,173
-98% -$6.22M 0.03% 258
2025
Q2 		$6.3M Buy
136,127
+268
+0.2% +$13.2K 1.24% 39
2025
Q1 		$8.29M Buy
135,859
+127,239
+1,476% +$7.42M 1.75% 23
2024
Q4 		$488K Buy
+8,620
New +$482K 0.1% 140
2023
Q2 		– Sell
-4,677
Closed -$324K – 305
2023
Q1 		$324K Hold
4,677
– – 0.09% 153
2022
Q4 		$337K Buy
+4,677
New +$353K 0.09% 150
2020
Q3 		– Sell
-3,601
Closed -$205K – 254
2020
Q2 		$205K Buy
+3,601
New +$215K 0.08% 149
2018
Q1 		– Sell
-159
Closed -$10K – 345
2017
Q4 		$10K Buy
159
+59
+59% +$3.69K ﹤0.01% 268
2017
Q3 		$6K Buy
+100
New +$5.84K ﹤0.01% 288
2016
Q3 		– Sell
-31
Closed -$2K – 284
2016
Q2 		$2K Hold
31
– – ﹤0.01% 156
2016
Q1 		$2K Hold
31
– – ﹤0.01% 146
2015
Q4 		$2K Buy
+31
New +$2.05K ﹤0.01% 150
2014
Q3 		– Sell
-183,319
Closed -$8.89M – 149
2014
Q2 		$8.89M Sell
183,319
-8,183
-4% -$403K 1.76% 38
2014
Q1 		$9.95M Buy
+191,502
New +$10.2M 1.95% 32

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Contravisory Investment Management's BMY Position: Q1 2026 in Review

Contravisory Investment Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 448 shares — an estimated $24.2K sold.

Contravisory Investment Management first reported a position in BMY in Q1 2014 and held it in 15 quarters. The position peaked at $9.95M in Q1 2014. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Contravisory Investment Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Contravisory Investment Management sold 448 Bristol-Myers Squibb shares in Q1 2026, an estimated $24.2K.
  • Contravisory Investment Management first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 15 quarters.
  • Contravisory Investment Management's Bristol-Myers Squibb position peaked at $9.95M in Q1 2014.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Contravisory Investment Management's 13F filing for Q1 2026, filed 20 Apr 2026.